A p53/miR-30a/ZEB2 axis controls triple negative breast cancer aggressiveness
Related Biotechnology, Pharmaceutical and Healthcare News
Original Article: A p53/miR-30a/ZEB2 axis controls triple negative breast cancer aggressiveness
NEXT ARTICLE
More From BioPortfolio on "A p53/miR-30a/ZEB2 axis controls triple negative breast cancer aggressiveness"